Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Failure of the smallpox vaccine to develop a skin lesion in vaccinia virus-naïve individuals is related to differences in antibody profiles before vaccination, not after.

Tan X, Chun S, Pablo J, Felgner P, Liang X, Davies DH.

Clin Vaccine Immunol. 2012 Mar;19(3):418-28. doi: 10.1128/CVI.05521-11. Epub 2012 Jan 18.

2.

Measurement of antibody responses to Modified Vaccinia virus Ankara (MVA) and Dryvax(®) using proteome microarrays and development of recombinant protein ELISAs.

Hermanson G, Chun S, Felgner J, Tan X, Pablo J, Nakajima-Sasaki R, Molina DM, Felgner PL, Liang X, Davies DH.

Vaccine. 2012 Jan 11;30(3):614-25. doi: 10.1016/j.vaccine.2011.11.021. Epub 2011 Nov 17.

3.

Response to smallpox vaccine in persons immunized in the distant past.

Frey SE, Newman FK, Yan L, Lottenbach KR, Belshe RB.

JAMA. 2003 Jun 25;289(24):3295-9. Erratum in: JAMA. 2003 Jul 16;290(3):334.

PMID:
12824212
4.

Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax.

Davies DH, Wyatt LS, Newman FK, Earl PL, Chun S, Hernandez JE, Molina DM, Hirst S, Moss B, Frey SE, Felgner PL.

J Virol. 2008 Jan;82(2):652-63. Epub 2007 Oct 31.

5.

Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine.

Newman FK, Frey SE, Blevins TP, Mandava M, Bonifacio A Jr, Yan L, Belshe RB.

J Clin Microbiol. 2003 Jul;41(7):3154-7.

6.

Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.

Berhanu A, Wilson RL, Kirkwood-Watts DL, King DS, Warren TK, Lund SA, Brown LL, Krupkin AK, Vandermay E, Weimers W, Honeychurch KM, Grosenbach DW, Jones KF, Hruby DE.

J Virol. 2008 Apr;82(7):3517-29. doi: 10.1128/JVI.01854-07. Epub 2008 Jan 16.

7.

Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.

Meseda CA, Garcia AD, Kumar A, Mayer AE, Manischewitz J, King LR, Golding H, Merchlinsky M, Weir JP.

Virology. 2005 Sep 1;339(2):164-75.

8.

Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults.

Kennedy JS, Gurwith M, Dekker CL, Frey SE, Edwards KM, Kenner J, Lock M, Empig C, Morikawa S, Saijo M, Yokote H, Karem K, Damon I, Perlroth M, Greenberg RN.

J Infect Dis. 2011 Nov;204(9):1395-402. doi: 10.1093/infdis/jir527. Epub 2011 Sep 15.

9.

Cellular immune responses to diluted and undiluted aventis pasteur smallpox vaccine.

Rock MT, Yoder SM, Talbot TR, Edwards KM, Crowe JE Jr.

J Infect Dis. 2006 Aug 15;194(4):435-43. Epub 2006 Jul 7.

PMID:
16845626
10.

Characterization and use of mammalian-expressed vaccinia virus extracellular membrane proteins for quantification of the humoral immune response to smallpox vaccines.

García AD, Meseda CA, Mayer AE, Kumar A, Merchlinsky M, Weir JP.

Clin Vaccine Immunol. 2007 Aug;14(8):1032-44. Epub 2007 Jun 27.

11.

Smallpox vaccine, ACAM2000: Sites and duration of viral shedding and effect of povidone iodine on scarification site shedding and immune response.

Pittman PR, Garman PM, Kim SH, Schmader TJ, Nieding WJ, Pike JG, Knight R, Johnston SC, Huggins JW, Kortepeter MG, Korman L, Ranadive M, Quinn X, Meyers MS.

Vaccine. 2015 Jun 12;33(26):2990-6. doi: 10.1016/j.vaccine.2015.04.062. Epub 2015 Apr 27.

PMID:
25930115
12.

Clinical responses to smallpox vaccine in vaccinia-naive and previously vaccinated populations: undiluted and diluted Lancy-Vaxina vaccine in a single-blind, randomized, prospective trial.

Kim SH, Yeo SG, Jang HC, Park WB, Lee CS, Lee KD, Kim HB, Kim NJ, Kim YT, Jee Y, Cho H, Oh MD, Choe KW.

J Infect Dis. 2005 Sep 15;192(6):1066-70. Epub 2005 Aug 11.

PMID:
16107961
13.

Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax.

Seaman MS, Wilck MB, Baden LR, Walsh SR, Grandpre LE, Devoy C, Giri A, Noble LC, Kleinjan JA, Stevenson KE, Kim HT, Dolin R.

J Infect Dis. 2010 May 1;201(9):1353-60. doi: 10.1086/651560.

14.

Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naïve and vaccinia-immune individuals.

Parrino J, McCurdy LH, Larkin BD, Gordon IJ, Rucker SE, Enama ME, Koup RA, Roederer M, Bailer RT, Moodie Z, Gu L, Yan L, Graham BS; VRC 201/203 Study Team..

Vaccine. 2007 Feb 9;25(8):1513-25. Epub 2006 Nov 7.

15.

Antibody responses to vaccinia membrane proteins after smallpox vaccination.

Lawrence SJ, Lottenbach KR, Newman FK, Buller RM, Bellone CJ, Chen JJ, Cohen GH, Eisenberg RJ, Belshe RB, Stanley SL Jr, Frey SE.

J Infect Dis. 2007 Jul 15;196(2):220-9. Epub 2007 Jun 4.

16.

Human antibody responses to the polyclonal Dryvax vaccine for smallpox prevention can be distinguished from responses to the monoclonal replacement vaccine ACAM2000.

Pugh C, Keasey S, Korman L, Pittman PR, Ulrich RG.

Clin Vaccine Immunol. 2014 Jun;21(6):877-85. doi: 10.1128/CVI.00035-14. Epub 2014 Apr 23.

17.

Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial.

Talbot TR, Stapleton JT, Brady RC, Winokur PL, Bernstein DI, Germanson T, Yoder SM, Rock MT, Crowe JE Jr, Edwards KM.

JAMA. 2004 Sep 8;292(10):1205-12. Erratum in: JAMA. 2004 Nov 24;292(20):2470.

PMID:
15353533
18.

Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax.

Midgley CM, Putz MM, Weber JN, Smith GL.

J Gen Virol. 2008 Dec;89(Pt 12):2992-7. doi: 10.1099/vir.0.2008/004440-0.

19.

Clinical and immunological responses to undiluted and diluted smallpox vaccine with vaccinia virus of Lister strain.

Hsieh SM, Chen SY, Sheu GC, Hung MN, Chou WH, Chang SC, Hsu KH.

Vaccine. 2006 Jan 23;24(4):510-5. Epub 2005 Aug 18.

PMID:
16139395
20.

Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination.

Kennedy JS, Frey SE, Yan L, Rothman AL, Cruz J, Newman FK, Orphin L, Belshe RB, Ennis FA.

J Infect Dis. 2004 Oct 1;190(7):1286-94. Epub 2004 Aug 30.

PMID:
15346340

Supplemental Content

Support Center